Skip to main content

Find Clinical Trials

Home
Conditions
Breast Neoplasms

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

617 public trials 220 recruiting studies

Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer

NCT01969032

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Russian Cancer Research Center named after N.N.Blokhin RAMS Moscow, Russia

View Trial Details

Completed

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

NCT01077453

Conditions: Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +10 more
Locations: Arizona Cancer Center - Tucson Tucson, Arizona, United States

University of Arizona Health Sciences Center Tucson, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

NCT01367639

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +20 more
Locations: Sheba Medical Center Tel Aviv, Israel

View Trial Details

Completed

Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers

NCT00225927

Conditions: Breast Cancer Invasive Nos, Breast Carcinoma In Situ, Breast Diseases, +10 more
Locations: St. Joseph's Healthcare Hamilton, Ontario, Canada

Juravinski Cancer Centre Hamilton, Ontario, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Establishing an Inflammatory Breast Cancer Registry

NCT00340158

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +13 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Terminated

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

NCT05827614

Conditions: Anogenital Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations: UCLA Medical Center Los Angeles, California, United States

Sarcoma Oncology Santa Monica, California, United States

HealthONE Denver, Colorado, United States

Florida Cancer Specialists Lake Mary, Florida, United States

View all 16 locations

View Trial Details

Suspended

Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

NCT06671912

Conditions: Adenocarcinoma, Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, +18 more
Locations: Katmai Oncology Group Anchorage, Alaska, United States

Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States

CTCA at Western Regional Medical Center Goodyear, Arizona, United States

Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States

View all 732 locations

View Trial Details